CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-20 | Pulik Richard CFO | Shares withheld for taxes | −1,503 | $11.45 | $17K | 399,056 |
| 2025-06-20 | Venker Eric President & COO | Option exercise 10b5-1 | +100,000 | $3.85 | $385K | 1,562,223 |
| 2025-06-20 | Venker Eric President & COO | Sale 10b5-1 | −100,000 | $11.45 | $1.1M | 1,462,223 |
| 2025-06-20 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 8,238,897 | ||
| 2025-06-20 | Ramaswamy Vivek 10% owner | Sale | −577,007 | $11.46 | $6.6M | 37,284,108 |
| 2025-06-18 | Ramaswamy Vivek 10% owner | Sale | −565,266 | $11.45 | $6.5M | 37,861,115 |
| 2025-06-06 | Ramaswamy Vivek 10% owner | Sale | −200,800 | $11.19 | $2.2M | 38,426,381 |
| 2025-06-04 | Ramaswamy Vivek 10% owner | Sale | −547,430 | $11.34 | $6.2M | 38,627,181 |
| 2025-06-03 | Venker Eric President & COO | Option exercise | +785,026 | $3.85 | $3.0M | 2,028,501 |
| 2025-06-03 | Venker Eric President & COO | Sale | −566,278 | $11.22 | $6.4M | 1,462,223 |
| 2025-06-03 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) | −785,026 | 8,338,897 | ||
| 2025-06-02 | Venker Eric President & COO | Option exercise | +600,000 | $3.85 | $2.3M | 1,677,197 |
| 2025-06-02 | Venker Eric President & COO | Sale | −433,722 | $11.07 | $4.8M | 1,243,475 |
| 2025-06-02 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) | −600,000 | 9,123,923 | ||
| 2025-05-28 | Pulik Richard CFO | Shares withheld for taxes | −1,653 | $10.62 | $18K | 400,559 |
| 2025-05-20 | Pulik Richard CFO | Shares withheld for taxes | −3,487 | $11.04 | $38K | 402,212 |
| 2025-05-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −39,148 | $11.04 | $432K | 1,077,197 |
| 2025-05-20 | Venker Eric President & COO | Option exercise 10b5-1 | +100,000 | $3.85 | $385K | 1,177,197 |
| 2025-05-20 | Venker Eric President & COO | Sale 10b5-1 | −100,000 | $10.95 | $1.1M | 1,077,197 |
| 2025-05-20 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 9,723,923 |
Page 22 of 29 · 570 trades